MA54823A - Composé hétérocyclique et son utilisation - Google Patents
Composé hétérocyclique et son utilisationInfo
- Publication number
- MA54823A MA54823A MA054823A MA54823A MA54823A MA 54823 A MA54823 A MA 54823A MA 054823 A MA054823 A MA 054823A MA 54823 A MA54823 A MA 54823A MA 54823 A MA54823 A MA 54823A
- Authority
- MA
- Morocco
- Prior art keywords
- heterocyclic compound
- heterocyclic
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019010536 | 2019-01-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA54823A true MA54823A (fr) | 2022-04-27 |
Family
ID=71736449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA054823A MA54823A (fr) | 2019-01-24 | 2020-01-23 | Composé hétérocyclique et son utilisation |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12637418B2 (fr) |
| EP (1) | EP3915638A4 (fr) |
| JP (1) | JP7541487B2 (fr) |
| MA (1) | MA54823A (fr) |
| WO (1) | WO2020153414A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3774800B1 (fr) * | 2018-03-28 | 2024-11-13 | Takeda Pharmaceutical Company Limited | Composé hétérocyclique et son utilisation |
| US12637418B2 (en) | 2019-01-24 | 2026-05-26 | Takeda Pharmaceutical Company Limited | Heterocyclic compounds as antagonist of NMDA |
| JP2021050161A (ja) | 2019-09-25 | 2021-04-01 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
| JP2021080177A (ja) | 2019-11-14 | 2021-05-27 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
| CN115354349B (zh) * | 2022-08-29 | 2025-07-18 | 河北农业大学 | 一种电催化制备过氧化氢的碳催化剂的制备方法及催化剂 |
| CN116120226A (zh) * | 2022-12-28 | 2023-05-16 | 湖南阿斯迪康药业有限公司 | 一种5-羟甲基烟腈的合成工艺 |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2492382A1 (fr) | 1980-10-22 | 1982-04-23 | Synthelabo | Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique |
| TW212792B (fr) * | 1991-09-13 | 1993-09-11 | Shell Internat Res Schappej B V | |
| US5252563A (en) | 1991-12-19 | 1993-10-12 | G. D. Searle & Company | 5,6,7,8-tetrahydro-imidazo[1,2-a]pyrimidine compounds for treatment of neurotoxic injury |
| CA2191979A1 (fr) | 1994-06-20 | 1995-12-28 | Muneo Takatani | Composes d'imidazole condenses, leur production et utilisation |
| JP3439551B2 (ja) | 1994-11-08 | 2003-08-25 | 富士写真フイルム株式会社 | ハロゲン化銀写真感光材料 |
| CA2214247C (fr) | 1995-03-14 | 2004-02-10 | Praecis Pharmaceuticals Incorporated | Modulateurs de l'agregation de substances amyloides |
| US6387938B1 (en) | 1996-07-05 | 2002-05-14 | Mochida Pharmaceutical Co., Ltd. | Benzimidazole derivatives |
| KR20000022398A (ko) | 1996-07-05 | 2000-04-25 | 모치다 에이 | 신규 벤조이미다졸 유도체 |
| EP1586584A1 (fr) | 1996-08-27 | 2005-10-19 | Praecis Pharmaceuticals Incorporated | Modulateurs de l'agrégation de peptides beta-amyloides, comprenant des D-aminoacides |
| US6420415B1 (en) | 1998-09-21 | 2002-07-16 | Takeda Chemical Industries, Ltd. | Thiol compounds, their production and use |
| JP2000159747A (ja) | 1998-09-21 | 2000-06-13 | Takeda Chem Ind Ltd | 新規チオ―ル誘導体、その製造法および用途 |
| US6331640B1 (en) | 1998-10-13 | 2001-12-18 | Hoffmann-La Roche Inc. | Diaminopropionic acid derivatives |
| EP1194449B1 (fr) | 1999-06-28 | 2010-09-22 | Oklahoma Medical Research Foundation | Inhibiteurs de memapsine 2 et son utilisation |
| TWI262185B (en) | 1999-10-01 | 2006-09-21 | Eisai Co Ltd | Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives |
| US6316474B1 (en) | 1999-10-29 | 2001-11-13 | Merck & Co., Inc. | 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists |
| AU1153601A (en) | 1999-10-29 | 2001-05-08 | Merck Sharp & Dohme Limited | Method to treat pain utilizing benzimidazole NMDA NR2B antagonists |
| US20020151534A1 (en) | 2001-02-02 | 2002-10-17 | Ries Uwe Joerg | Antithrombotic compounds |
| DE10111842A1 (de) | 2001-03-13 | 2002-09-19 | Boehringer Ingelheim Pharma | Antithrombotische Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel |
| EP1375472A4 (fr) | 2001-03-30 | 2008-12-10 | Eisai R&D Man Co Ltd | Compose de benzene et sel de ce compose |
| WO2002080899A1 (fr) | 2001-03-30 | 2002-10-17 | Eisai Co., Ltd. | Agent de traitement de maladie digestive |
| EP1390034A4 (fr) | 2001-04-03 | 2005-07-13 | Merck & Co Inc | Antagonistes de nmda/nr2b nonaryl-heterocyclo amidyle n-substitues |
| JPWO2003035641A1 (ja) | 2001-10-22 | 2005-02-10 | 塩野義製薬株式会社 | 新規カルバモイルピロリドン誘導体 |
| JP2004002405A (ja) | 2002-04-26 | 2004-01-08 | Takeda Chem Ind Ltd | 新規チオール誘導体、その製造法および用途 |
| CA2483515A1 (fr) | 2002-04-26 | 2003-11-06 | Takeda Pharmaceutical Company Limited | Nouveau derive de thiol, procede de production de ce derive et utilisation dudit derive |
| MY139563A (en) | 2002-09-04 | 2009-10-30 | Bristol Myers Squibb Co | Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| JP2004161716A (ja) | 2002-11-15 | 2004-06-10 | Takeda Chem Ind Ltd | Jnk阻害剤 |
| WO2004054977A1 (fr) | 2002-12-13 | 2004-07-01 | Cytopia Pty Ltd | Inhibiteurs de kinase a base de nicotinamide |
| CA2521907A1 (fr) | 2003-04-10 | 2004-10-21 | Pfizer Inc. | Composes bicycliques comme antagonistes du recepteur nr2b |
| US20050137187A1 (en) | 2003-12-23 | 2005-06-23 | Souers Andrew J. | Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| HUP0401523A3 (en) | 2004-07-29 | 2007-05-02 | Richter Gedeon Vegyeszet | Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them |
| JP5031745B2 (ja) | 2005-08-12 | 2012-09-26 | アストラゼネカ アクチボラグ | 代謝型グルタミン酸受容体増強性イソインドロン |
| US20080234318A1 (en) | 2005-08-31 | 2008-09-25 | Kristjan Gudmundsson | Chemical Compounds |
| AR057218A1 (es) | 2005-12-15 | 2007-11-21 | Astra Ab | Compuestos de oxazolidinona y su uso como pontenciadores del receptor metabotropico de glutamato |
| TWI403320B (zh) | 2005-12-16 | 2013-08-01 | Infinity Discovery Inc | 用於抑制bcl蛋白和結合夥伴間之交互作用的化合物及方法 |
| WO2007098352A2 (fr) | 2006-02-16 | 2007-08-30 | Boehringer Ingelheim International Gmbh | Pyridineamides substitués pouvant être employés en tant qu'inhibiteurs d'époxyde hydrolase soluble |
| JP2010120852A (ja) | 2007-03-09 | 2010-06-03 | Daiichi Sankyo Co Ltd | 新規なジアミド誘導体 |
| WO2009004430A1 (fr) | 2007-06-29 | 2009-01-08 | Pfizer Inc. | N-benzyl oxazolidinones et composés hétérocycliques apparentés comme potentialisateurs de récepteurs du glutamate |
| AU2010210426B2 (en) | 2009-02-06 | 2015-06-11 | Imago Pharmaceuticals, Inc. | Inhibitors of Jun N-terminal kinase |
| BR112012021806A2 (pt) | 2010-03-01 | 2015-09-08 | Myrexis Inc | compostos e seus usos terapêusticos. |
| US8404859B2 (en) | 2011-03-16 | 2013-03-26 | Hoffmann-La Roche Inc. | Thiazole and thiophene compounds |
| EP2694509B1 (fr) | 2011-04-05 | 2016-05-18 | Pfizer Limited | Dérivés de pyrrolo-[2,3-d]pyrimidine en tant qu'inhibiteurs des kinases associées à la tropomyosine |
| WO2012158691A1 (fr) | 2011-05-19 | 2012-11-22 | The Board Of Trustees Of The Leland Stanford Junior University | Composés antiprolifératifs et procédés pour leur utilisation |
| EP2721029B1 (fr) | 2011-06-16 | 2018-07-18 | Merck Sharp & Dohme Corp. | Dérivés d'imidazopyridin-2-one |
| FR2998892B1 (fr) | 2012-12-04 | 2015-01-02 | Pf Medicament | Derives d'aminocyclobutane, leur procede de preparation et leur utilisation a titre de medicaments |
| AR094929A1 (es) | 2013-02-28 | 2015-09-09 | Bristol Myers Squibb Co | Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2 |
| CA3188023C (fr) | 2013-03-08 | 2025-03-11 | Becton, Dickinson And Company | Dispositif de verrouillage d'accès de seringue intraveineuse |
| US9243001B2 (en) | 2013-03-15 | 2016-01-26 | Epizyme, Inc. | Substituted benzene compounds |
| US20160031907A1 (en) | 2013-03-15 | 2016-02-04 | Epizyme, Inc. | Substituted Benzene Compounds |
| CA2939639C (fr) | 2014-02-24 | 2023-01-24 | Takeda Gmbh | Proteines de fusion d'uti |
| CN107074788B (zh) | 2014-10-31 | 2019-09-20 | 厦门大学 | 取代杂环衍生物、其制备方法和用途 |
| US10202376B2 (en) | 2014-12-24 | 2019-02-12 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| TW201718574A (zh) | 2015-08-12 | 2017-06-01 | 美國禮來大藥廠 | Cgrp受體拮抗劑 |
| TWI636041B (zh) | 2015-08-12 | 2018-09-21 | 美國禮來大藥廠 | Cgrp受體拮抗劑 |
| WO2017033946A1 (fr) | 2015-08-25 | 2017-03-02 | 武田薬品工業株式会社 | Composé hétérocyclique |
| PL3439477T3 (pl) | 2016-04-08 | 2020-11-16 | Syngenta Participations Ag | Mikrobiocydowe pochodne oksadiazolowe |
| EP3636281B1 (fr) | 2017-05-09 | 2023-11-01 | Zhejiang University | Méthode de traitement de la dépression, et composition pharmaceutique |
| US11230541B2 (en) | 2017-07-28 | 2022-01-25 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| EP3774800B1 (fr) | 2018-03-28 | 2024-11-13 | Takeda Pharmaceutical Company Limited | Composé hétérocyclique et son utilisation |
| AU2019362061B2 (en) | 2018-10-18 | 2024-09-26 | Essa Pharma Inc | Androgen receptor modulators and methods for their use |
| WO2020154314A1 (fr) | 2019-01-21 | 2020-07-30 | Transit Scientific, LLC | Cathéters à hypotube |
| US12637418B2 (en) | 2019-01-24 | 2026-05-26 | Takeda Pharmaceutical Company Limited | Heterocyclic compounds as antagonist of NMDA |
| WO2020196828A1 (fr) | 2019-03-28 | 2020-10-01 | 武田薬品工業株式会社 | Composé hétérocyclique contenant de l'azote |
| WO2020198710A1 (fr) | 2019-03-28 | 2020-10-01 | Essa Pharma, Inc. | Compositions et associations pharmaceutiques comprenant des inhibiteurs du récepteur des androgènes et leurs utilisations |
| JP2021050161A (ja) | 2019-09-25 | 2021-04-01 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
| JP2021080177A (ja) | 2019-11-14 | 2021-05-27 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
-
2020
- 2020-01-23 US US17/310,164 patent/US12637418B2/en active Active
- 2020-01-23 EP EP20744243.5A patent/EP3915638A4/fr active Pending
- 2020-01-23 WO PCT/JP2020/002216 patent/WO2020153414A1/fr not_active Ceased
- 2020-01-23 JP JP2020568192A patent/JP7541487B2/ja active Active
- 2020-01-23 MA MA054823A patent/MA54823A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US12637418B2 (en) | 2026-05-26 |
| US20220089525A1 (en) | 2022-03-24 |
| EP3915638A1 (fr) | 2021-12-01 |
| JPWO2020153414A1 (ja) | 2021-12-02 |
| WO2020153414A1 (fr) | 2020-07-30 |
| EP3915638A4 (fr) | 2022-10-19 |
| JP7541487B2 (ja) | 2024-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3816153A4 (fr) | Composé hétérocyclique et son utilisation | |
| EP3816154A4 (fr) | Composé hétérocyclique et son application | |
| EP4071145A4 (fr) | Composé inhibiteur de jak et son utilisation | |
| EP3932919A4 (fr) | Composé inhibiteur de jak et son utilisation | |
| EP3663281A4 (fr) | Composé hétérocyclique et son application | |
| EP3929199A4 (fr) | Nouveau composé hétérocyclique et utilisation associée | |
| EP3896060A4 (fr) | Composé hétérocyclique | |
| EP3798219A4 (fr) | Composé de dihydronaphtyridine substitué par phényle et son utilisation | |
| EP3895707A4 (fr) | Composé hétérocyclique | |
| MA43963A (fr) | Composé de pipéridine substituée et son utilisation | |
| EP3919055A4 (fr) | Composé hétérocyclique | |
| EP4066893A4 (fr) | Composé hétérocyclique | |
| EP3792248A4 (fr) | Composé benzamide et son application | |
| EP3950674A4 (fr) | Composé pyrrole amide et son utilisation | |
| EP3981769A4 (fr) | Composé de pyrrolopyrimidine et son utilisation | |
| EP3674352A4 (fr) | Composé dérivé de lignine et son utilisation | |
| MA52214A (fr) | Composé hétérocyclique et son utilisation | |
| EP3890738A4 (fr) | Composé macrocyclique et son utilisation | |
| EP3888652A4 (fr) | Composé hétérocyclique | |
| EP3681877A4 (fr) | Composé dérivé de pyrazole et son utilisation | |
| EP4039686A4 (fr) | Composé bicyclique et son utilisation | |
| EP3978468A4 (fr) | Composé et composition | |
| MA52297A (fr) | Composé hétérocyclique | |
| EP4082614A4 (fr) | Composé acylsulfamide et son utilisation pharmaceutique | |
| EP4361138A4 (fr) | Composé sulfoximine et son utilisation |